Correlation Between ZyVersa Therapeutics and Silence Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Silence Therapeutics PLC, you can compare the effects of market volatilities on ZyVersa Therapeutics and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Silence Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Silence Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ZyVersa and Silence is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Silence Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Silence Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.42 times more return on investment than Silence Therapeutics. However, ZyVersa Therapeutics is 1.42 times more volatile than Silence Therapeutics PLC. It trades about -0.15 of its potential returns per unit of risk. Silence Therapeutics PLC is currently generating about -0.34 per unit of risk. If you would invest 201.00 in ZyVersa Therapeutics on August 31, 2024 and sell it today you would lose (94.00) from holding ZyVersa Therapeutics or give up 46.77% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Silence Therapeutics PLC
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Silence Therapeutics PLC |
ZyVersa Therapeutics and Silence Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Silence Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Silence Therapeutics vs. Cue Biopharma | Silence Therapeutics vs. Eliem Therapeutics | Silence Therapeutics vs. Inhibrx | Silence Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |